Akero Therapeutics Reports First Quarter 2020 Financial Results,

We remain on schedule to initiate our Phase 2b clinical trial in NASH … previous clinical trials evaluating AKR-001 in patients with Type 2 diabetes., We remain on schedule to initiate our Phase 2b clinical trial in NASH … previous clinical trials evaluating AKR-001 in patients with Type 2 diabetes., Read More

Scroll to Top